99 related articles for article (PubMed ID: 34548879)
1. Correlation of sample-to-cut-off ratio of anti-SARS-CoV-2 IgG antibody chemiluminescent assay with neutralization activity: a prospective multi-centric study in India.
Tiwari AK; Negi G; Jaiswal RM; Aggarwal G; Yadav N; Kumar V; Kulathu K
ISBT Sci Ser; 2021 Nov; 16(4):269-275. PubMed ID: 34548879
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
Takahashi M; Saito K; Ai T; Nojiri S; Khasawneh A; Paran FJ; Horiuchi Y; Takei S; Yamamoto T; Wakita M; Hiki M; Miida T; Naito T; Takahashi K; Tabe Y
PLoS One; 2023; 18(1):e0279779. PubMed ID: 36693058
[TBL] [Abstract][Full Text] [Related]
3. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
4. Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
Ismail A; Shurrab FM; Al-Jighefee HT; Al-Sadeq DW; Qotba H; Al-Shaar IA; Yassine HM; Abu-Raddad LJ; Nasrallah GK
Front Biosci (Landmark Ed); 2021 Jul; 26(7):198-206. PubMed ID: 34340267
[No Abstract] [Full Text] [Related]
5. Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods.
Mendoza R; Silver M; Zuretti AR; Christian M; Das B; Norin AJ; Borgen P; Libien J; Bluth MH
J Blood Med; 2021; 12():157-164. PubMed ID: 33762863
[TBL] [Abstract][Full Text] [Related]
6. Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors.
Tiwari AK; Aggarwal G; Kale P; Yadav N; Kumar V; Singh G; Cheirmaraj K; Krishnan K
Transfus Apher Sci; 2024 Jun; 63(3):103937. PubMed ID: 38678985
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.
Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X
Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
[TBL] [Abstract][Full Text] [Related]
9. Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Lee B; Ko JH; Park J; Moon HW; Baek JY; Jung S; Lim HY; Kim KC; Huh K; Cho SY; Kang CI; Chung DR; Huh HJ; Chung CR; Kim YJ; Joo EJ; Kang ES; Peck KR
Front Cell Infect Microbiol; 2022; 12():822599. PubMed ID: 35493733
[TBL] [Abstract][Full Text] [Related]
10. Utility of COVID-19 Seropositive Plasma as Convalescent Plasma: An Immune and Neutralization Antibody Seroprevalence Analysis in Blood Donors for Future Potential Pandemic Readiness.
Jain A; Negi G; Kaur D; S V; Saxena V
Cureus; 2024 Mar; 16(3):e57149. PubMed ID: 38681329
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
[TBL] [Abstract][Full Text] [Related]
12. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Körper S; Jahrsdörfer B; Corman VM; Pilch J; Wuchter P; Blasczyk R; Müller R; Tonn T; Bakchoul T; Schäfer R; Juhl D; Schwarz T; Gödecke N; Burkhardt T; Schmidt M; Appl T; Eichler H; Klüter H; Drosten C; Seifried E; Schrezenmeier H
Transfus Med Hemother; 2021 May; 48(3):137-147. PubMed ID: 34177417
[TBL] [Abstract][Full Text] [Related]
13. Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies.
Lokida D; Karyana M; Kosasih H; Mardian Y; Sugiyono RI; Arlinda D; Lukman N; Salim G; Butar Butar DP; Naysilla AM; Irmansyah
Heliyon; 2022 Dec; 8(12):e12614. PubMed ID: 36575657
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
Nicholson S; Karapanagiotidis T; Khvorov A; Douros C; Mordant F; Bond K; Druce J; Williamson DA; Purcell D; Lewin SR; Sullivan S; Subbarao K; Catton M
Open Forum Infect Dis; 2021 Jul; 8(7):ofab239. PubMed ID: 34258311
[TBL] [Abstract][Full Text] [Related]
15. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
17. Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors.
De Giorgi V; West KA; Henning AN; Chen L; Holbrook MR; Gross R; Liang J; Postnikova E; Trenbeath J; Pogue S; Scinto T; Alter HJ; Cantilena CC
medRxiv; 2021 Mar; ():. PubMed ID: 33758897
[TBL] [Abstract][Full Text] [Related]
18. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
Walker GJ; Naing Z; Ospina Stella A; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557418
[TBL] [Abstract][Full Text] [Related]
19. Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel.
Lester SN; Stumpf M; Freeman BD; Mills L; Schiffer J; Semenova V; Jia T; Desai R; Browning P; Alston B; Ategbole M; Bolcen S; Chen A; David E; Manitis P; Tatum H; Qin Y; Zellner B; Drobeniuc J; Tejada-Strop A; Chatterjee P; Shrivastava-Ranjan P; Jenks MH; McMullan LK; Flint M; Spiropoulou CF; Niemeyer GP; Werner BJ; Bean CJ; Johnson JA; Hoffmaster AR; Satheshkumar PS; Schuh AJ; Owen SM; Thornburg NJ
Access Microbiol; 2024; 6(2):. PubMed ID: 38482357
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
